VUMC Limited Submission Opportunity: Mary Kay Foundation Translational Cancer Research Grant
Vanderbilt University Medical Center (VUMC) anticipates the opportunity to nominate one candidate for the Mary Kay Foundation Translational Cancer Research Grant program for 2018. These awards provide $100,000 over two years to support translational research in ovarian, uterine, breast, or cervical cancer.
The Mary Kay Foundation seeks to fund innovative research that will provide a scientific link between laboratory research and the clinic. Ultimately, such research would lead to improvement in the diagnosis, prognosis, prevention or treatment of cancer.
You can find a list of the previous award recipients here.
- Maximum $100,000 award includes direct and indirect costs over a two-year period. (Indirects may not exceed 15%).
- U.S. citizenship is not required.
Internal Application Process:
Anyone interested in being considered as VUMC’s nominee must submit the following to LSO@vanderbilt.edu by 5 p.m. on Nov. 30. Please combine your materials into a single PDF and reference the program name in the subject line of the email.
- Brief (2 page maximum) research plan including summary budget;
- Brief statement of support from department chair/center director;
- Brief CV or NIH Biosketch
The chosen nominee will submit a full proposal to the foundation by the anticipated deadline of early February.
Direct all questions about the application process to LSO@vanderbilt.edu. For questions about the foundation or its interests and priorities, please contact Adele White (email@example.com), VUMC Corporate and Foundation Relations.